Heron Therapeutics Inc vs Oracle Corporation — how do they compare? Heron Therapeutics Inc trades at $0.46 (market cap $91.46M), while Oracle Corporation trades at $127.96 (market cap $349.63B). The key difference: Oracle Corporation is far larger — about 3822.8× Heron Therapeutics Inc's market cap, and Oracle Corporation pays a 1.65% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | ORCL | |
|---|---|---|
Market Cap | $91.46M | $349.63B |
Sector | Health | Technology |
52-Week High | $1.96 | $328.33 |
52-Week Low | $0.39 | $121.37 |
Enterprise Value | $189.36M | $478.88B |
Dividend Yield | — | 1.65% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Oracle (ORCL) trades at $126.48, up 1.78% today, with a strong fundamental backdrop including revenue growth to $57.40B in 2025 and a net income margin of 25.37%. Recent quarters have consistently beaten EPS estimates, and analyst consensus is bullish with a $253.30 price target. Technicals show a bearish overall signal but with bullish oscillators, and the stock faces support near $125.
The outlook is positive given Oracle's AI infrastructure expansion and earnings momentum, but risks include high debt levels and competitive pressures. The stock offers growth potential if execution continues, yet investors should weigh valuation multiples against sector peers.
Trailing returns across standard periods
Latest headlines on both assets
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →Oracle provides database technology and enterprise resource planning, or ERP, software to enterprises around the world. Founded in 1977, Oracle pioneered the first commercial SQL-based relational database management system. Today, Oracle has 430,000 customers in 175 countries, supported by its base of 136,000 employees.
Read more on ORCL →